Amundi
ABMD

Amundi’s Abiomed Inc ABMD Stock Holding History

Amundi’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-189,134
Closed -$50M – 2018
2022
Q3 		$50M Buy
189,134
+76,742
+68% +$20.7M 0.03% 506
2022
Q2 		$29.1M Buy
112,392
+45,469
+68% +$12.3M 0.02% 545
2022
Q1 		$21.3M Sell
66,923
-14,783
-18% -$4.55M 0.01% 646
2021
Q4 		$25.1M Sell
81,706
-6,499
-7% -$2.2M 0.02% 627
2021
Q3 		$28.7M Sell
88,205
-3,375
-4% -$1.14M 0.02% 587
2021
Q2 		$28.6M Buy
+91,580
New +$28.1M 0.02% 587

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Amundi's ABMD Position: Q4 2022 in Review

Amundi sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 189,134 shares — an estimated $50M sold.

Amundi first reported a position in ABMD in Q2 2021 and held it in 6 quarters. The position peaked at $50M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Amundi reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Amundi sold 189,134 Abiomed Inc shares in Q4 2022, an estimated $50M.
  • Amundi first reported a position in Abiomed Inc in Q2 2021 and held it in 6 quarters.
  • Amundi's Abiomed Inc position peaked at $50M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Amundi's 13F filing for Q4 2022, filed 14 Feb 2023.